Get the app
US › Healthcare

PACS Group, Inc. (PACS)

US · Healthcare · Medical Care Facilities

$49.60-1.20%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$1.50B
Revenue YoY
+11.5%
Net profit
$60.8M
Profit YoY
+16.1%
EPS
$0.63
EPS estimate
$0.56
Net margin
4.1%

EPS came in at 0.63 against a street estimate of 0.56 — a beat of 12.5%.

Key statistics

Market cap
$7.95B
P/E
27.3
Forward P/E
17.6
P/B
6.66
Book value
$6.04
EPS (TTM)
$1.84
52-week high
$51.68
52-week low
$10.31
50-day MA
$44.26
200-day MA
$39.78
Beta
-0.14

Analyst view

Analysts rate PACS Group, Inc. a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $59.00.

From the latest earnings call · 2026-08-05

CONFIDENT PACS delivered Q2 revenue +9.1% YoY to $1.43B; net income +50%; adjusted EBITDA +25% with margin expansion to 11.7%. Same-store occupancy up 150bps. Raised FY26 guidance; closed 20 Eduro Texas facilities; 14 more expected Q3-Q4. Q2 2026 Eduro transaction adds 3,633 SNF beds across Texas, Montana, South Dakota, North Dakota, New Mexico, Utah. First 20 facilities closed August 1, 2026; remainder expected Q3-Q4. Analysts pressed on back-half momentum, ramping cohort drivers, and payer dynamics. Management emphasized quality as competitive moat, confirmed modest Eduro integration, flagged pending Ohio/California supplemental payments as upside not in guidance. 2026-08-05…

Full summary in the app.

Shareholding

Insiders
68.62%
Institutions
31.79%

Largest institutional holders

FundStake
Cohen & Steers Inc5.27%
FMR Inc3.92%
BlackRock Inc2.62%
Crewe Advisors LLC2.09%
American Century Companies Inc1.96%
Ameriprise Financial Inc1.26%
Vanguard Portfolio Management, LLC1.25%
Vanguard Capital Management, LLC1.16%

Recent filings & reports

DocumentDate
Quarterly report · Q3 2026
HEADLINE NUMBERS • For the three months ended September 30, 2026, revenue was $1,498,578 thousand, up from $1,344,567 thousand in the same period of
2026-11-03
Results announced · Q4 2026
HEADLINE NUMBERS • Third-quarter 2026 revenue was $1.50 billion, up 11.5% year over year. • Net income was $60.8 million, up 16.2% from $52.3 millio
2026-11-03
Board / officer change · Q3 2026
PACS GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Report Date: September 18, 2026 (filed September 21, 2026) • Company: PACS Group, Inc., Delaw
2026-09-21
Quarterly report · Q2 2026
PACS GROUP, INC. – Q2 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total Revenue (6 months): $2,848.5 million (up 10.1% vs. $2,586.4 million in 2025) •
2026-08-04
Results announced · Q3 2026
PACS GROUP, INC. — Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $1.43 billion in Q2 2026, up 9.1% year-over-year • Net income: $76.3 million
2026-08-04
Shareholder vote results · Q2 2026
PACS GROUP, INC. – DOCUMENT SUMMARY HEADLINE NUMBERS • Annual Meeting Date: June 10, 2026 • Shareholder Participation: 152,966,362 shares represente
2026-06-15
Quarterly report · Q1 2026
PACS GROUP, INC. – Q1 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue: $1,420,494 thousand (Q1 2026) vs. $1,277,150 thousand (Q1 2025) – up
2026-05-11
Results announced · Q2 2026
PACS GROUP, INC. - Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $1.42 billion, up 11.2% year-over-year • Net income: $80.7 million, up 184.2
2026-05-11

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for PACS Group, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.